Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Samar El-Kalyoubi, Samiha A. El-Sebaey, Ahmed A. El-Sayed, Moustafa S. Abdelhamid, Fatimah Agili & Sherin M. Elfeky. (2023) Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Peng Zhang, Congcong Shi, Tongbao Dong, Juntao Song & Gang Du. The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids. Future Medicinal Chemistry 0:0, pages 1-20.
Read now
Read now
Articles from other publishers (3)
Yuming Zhang, Lianhai Shan, Wentao Tang, Yating Ge, ChengXian Li & Jifa Zhang. (2024) Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications. Journal of Medicinal Chemistry 67:7, pages 5185-5215.
Crossref
Crossref
Meng Zhou, Ying Liu, Shuo Wang, Jiankang Feng, Huiyan Ni, Chichong Lu & Guofan Jin. (2023) A novel strategy to bind pyrimidine sulfonamide derivatives with odd even chains: exploration of their design, synthesis and biological activity evaluation. Molecular Diversity.
Crossref
Crossref
Z.-Y. Tan, J. Deng, Q.-X. Ye, Z.-F. Zhang & T.-Y. Luo. (2023) Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review). Russian Journal of General Chemistry 93:10, pages 2645-2662.
Crossref
Crossref